Cross-reactive immune responses against Mycobacterium bovis BCG in mice infected with non-tuberculous mycobacteria belonging to the MAIS-Group

被引:28
作者
Lozes, E
Denis, O
Drowart, A
Jurion, F
Palfliet, K
Vanonckelen, A
DeBruyn, J
DeCock, M
VanVooren, JP
Huygen, K
机构
[1] INST PASTEUR,DEPT VIROL,LAB MYCOBACTERIAL IMMUNOL,B-1180 BRUSSELS,BELGIUM
[2] FREE UNIV BRUSSELS,ERASME HOSP,DEPT CARDIORESP PHYSIOL,B-1050 BRUSSELS,BELGIUM
关键词
D O I
10.1046/j.1365-3083.1997.d01-99.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Two bacillus Calmette-Guerin (BCG)-susceptible mouse strains, BALB/c and C57BL/6, were infected intravenously with Mycobacterium intracellulare, M. avium or M. scrofulaceum and monitored during 3 months for mycobacterial replication and antibody and Th1-type cytokine production in response to cytoplasmic and secreted antigens from M. bovis BCG. Whereas initial colony-forming unit (CFU) counts of M. intracellulare and M. avium were higher in lungs than in spleen, the opposite was observed for M. scrofulaceum. Mycobacterium intracellulare was the most virulent species and its replication could not be controlled in either mouse strain. It also induced the strongest antibody response. Mycobacterium avium was eliminated in both mouse strains and M. scofulaceum finally was eliminated in C57BL/6 but multiplied in spleen from BALB/c mice. Significant sustained interleukin-2 and interferon-gamma production towards BCG antigens was only found in M. scrofulaceum infection. As in BCG-vaccination, M. scrofulaceum-infected C57BL/6 mice demonstrated a higher response towards whole BCG culture filtrate, BCG extract and purified antigen 85 complex (Ag85) from BCG than did BALB/c mice. The data suggest that the presence of M. scrifulaceum in the environment may possibly interfere in genetically predisposed subjects with BCG vaccine and its protective efficacy against M. tuberculosis.
引用
收藏
页码:16 / 26
页数:11
相关论文
共 33 条
[2]   ROLE OF GAMMA-INTERFERON AND TUMOR-NECROSIS-FACTOR-ALPHA DURING T-CELL-INDEPENDENT AND T-CELL-DEPENDENT PHASES OF MYCOBACTERIUM-AVIUM INFECTION [J].
APPELBERG, R ;
CASTRO, AG ;
PEDROSA, J ;
SILVA, RA ;
ORME, IM ;
MINOPRIO, P .
INFECTION AND IMMUNITY, 1994, 62 (09) :3962-3971
[3]  
BELISLE JT, 1995, 30 US JAP C TUB LEPR, P75
[4]  
Bloom Barry R., 1994, P531
[5]   TUBERCULOSIS - COMMENTARY ON A REEMERGENT KILLER [J].
BLOOM, BR ;
MURRAY, CJL .
SCIENCE, 1992, 257 (5073) :1055-1064
[6]   EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE [J].
COLDITZ, GA ;
BREWER, TF ;
BERKEY, CS ;
WILSON, ME ;
BURDICK, E ;
FINEBERG, HV ;
MOSTELLER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :698-702
[7]   PURIFICATION, PARTIAL CHARACTERIZATION, AND IDENTIFICATION OF A SKIN-REACTIVE PROTEIN ANTIGEN OF MYCOBACTERIUM-BOVIS BCG [J].
DEBRUYN, J ;
BOSMANS, R ;
TURNEER, M ;
WECKX, M ;
NYABENDA, J ;
VANVOOREN, JP ;
FALMAGNE, P ;
WIKER, HG ;
HARBOE, M .
INFECTION AND IMMUNITY, 1987, 55 (01) :245-252
[8]   PURIFICATION, CHARACTERIZATION AND IDENTIFICATION OF A 32 KDA PROTEIN ANTIGEN OF MYCOBACTERIUM-BOVIS BCG [J].
DEBRUYN, J ;
HUYGEN, K ;
BOSMANS, R ;
FAUVILLE, M ;
LIPPENS, R ;
VANVOOREN, JP ;
FALMAGNE, P ;
WECKX, M ;
WIKER, HG ;
HARBOE, M ;
TURNEER, M .
MICROBIAL PATHOGENESIS, 1987, 2 (05) :351-366
[9]   ISOELECTROPHORETIC CHARACTERIZATION OF PROTEIN ANTIGENS PRESENT IN MYCOBACTERIAL CULTURE FILTRATES AND RECOGNIZED BY MONOCLONAL-ANTIBODIES DIRECTED AGAINST THE MYCOBACTERIUM-BOVIS BCG ANTIGEN 85 COMPLEX [J].
DROWART, A ;
DEBRUYN, J ;
HUYGEN, K ;
DAMIANI, G ;
GODFREY, HP ;
STELANDRE, M ;
YERNAULT, JC ;
VANVOOREN, JP .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1992, 36 (05) :697-702
[10]   VARIATION IN PROTECTION BY BCG - IMPLICATIONS OF AND FOR HETEROLOGOUS IMMUNITY [J].
FINE, PEM .
LANCET, 1995, 346 (8986) :1339-1345